成都先導(688222.SH):聚焦AI分子生成和評估、高精度結合自由能計算以及AI成藥性評估
格隆匯2月14日丨成都先導(688222.SH)在互動平台表示,成都先導作為專注於早期新藥發現的創新驅動型生物技術公司,一直以來都對AI在藥物研發領域的進展保持高度關注並不斷進行相關探索和研究。目前,公司基於AI模型主要聚焦兩個方向的研究:1)利用成都先導已經積累的DEL篩選項目的大量數據集,構建靶點-萬億化合物的親和力預測模型,賦能高質量苗頭化合物發現環節;2)成都先導聚焦AI分子生成和評估、高精度結合自由能計算以及AI成藥性評估,結合公司搭建的高效化學合成和高通量化合物檢測平台,建設DEL+AI+自動化的 “設計-合成-測試-分析”(DMTA)分子優化的能力平台,乾濕結合加速化合物優化環節,賦能新藥優化環節。 除傳統AI for Science相關大模型解決特定科學問題以外,公司也期望串聯不同的技術平台和工具,協同工作,以提升數據處理、知識庫建設和工作流自動化的效率,進一步優化研發流程。“DeepSeek”所展現的通用能力以及其在企業內部的便捷部署特性,使我們能夠將其應用於公司日常運營和管理的多個環節。我們也已經把這類系統在公司的各種日常工作及經營管理中進行部署和推廣應用,整體提升工作能力和工作效率。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.